Long-term outcome and objective changes of anorectal function after biofeedback therapy for faecal incontinence

R. Ozturk, S. Niazi, M. Stessman, Satish Sanku Chander Rao

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Background: In the short-term, biofeedback therapy improves symptoms and anorectal function in patients with faecal incontinence but whether there is long-term improvement is incompletely understood. Aim: To prospectively evaluate bowel symptoms and anorectal function, both immediately and 12 months after biofeedback therapy. Methods: A total of 105 consecutive patients (male/female = 12/93) with faecal incontinence, unresponsive to supervised medical treatment were enrolled in biofeedback training consisting of biweekly pelvic muscle strengthening exercises, anal squeeze and sensory-motor coordination training, and reinforcement sessions at 3, 6 and 12 months. Anorectal manometry, saline continence test, stool diaries and bowel satisfaction scores were used to assess improvement. Results: 94/105 (male/female = 10/84) completed training and 11 dropped out. Sixty completed 1-year assessment. At 1-year, 63% reported no episodes of incontinence. Biofeedback decreased (P < 0.001) stool frequency and number of incontinence episodes and increased (P < 0.001) bowel satisfaction score, anal resting and squeeze pressures, squeeze duration and ability to retain saline infusion increased (P < 0.001), both immediately and at 1 year. Sensory thresholds decreased (P < 0.001). Conclusions: Biofeedback therapy produced sustained improvement in bowel symptoms and anorectal function. Because it is safe, inexpensive compared with other surgical interventions, and effective, biofeedback should be offered to incontinent patients unresponsive to medical therapy.

Original languageEnglish (US)
Pages (from-to)667-674
Number of pages8
JournalAlimentary Pharmacology and Therapeutics
Volume20
Issue number6
DOIs
StatePublished - Sep 15 2004
Externally publishedYes

Fingerprint

Fecal Incontinence
Therapeutics
Sensory Thresholds
Aptitude
Manometry
Biofeedback (Psychology)
Exercise
Pressure
Muscles

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this

Long-term outcome and objective changes of anorectal function after biofeedback therapy for faecal incontinence. / Ozturk, R.; Niazi, S.; Stessman, M.; Rao, Satish Sanku Chander.

In: Alimentary Pharmacology and Therapeutics, Vol. 20, No. 6, 15.09.2004, p. 667-674.

Research output: Contribution to journalArticle

@article{993c81e9a6534e2483e812531003dcd0,
title = "Long-term outcome and objective changes of anorectal function after biofeedback therapy for faecal incontinence",
abstract = "Background: In the short-term, biofeedback therapy improves symptoms and anorectal function in patients with faecal incontinence but whether there is long-term improvement is incompletely understood. Aim: To prospectively evaluate bowel symptoms and anorectal function, both immediately and 12 months after biofeedback therapy. Methods: A total of 105 consecutive patients (male/female = 12/93) with faecal incontinence, unresponsive to supervised medical treatment were enrolled in biofeedback training consisting of biweekly pelvic muscle strengthening exercises, anal squeeze and sensory-motor coordination training, and reinforcement sessions at 3, 6 and 12 months. Anorectal manometry, saline continence test, stool diaries and bowel satisfaction scores were used to assess improvement. Results: 94/105 (male/female = 10/84) completed training and 11 dropped out. Sixty completed 1-year assessment. At 1-year, 63{\%} reported no episodes of incontinence. Biofeedback decreased (P < 0.001) stool frequency and number of incontinence episodes and increased (P < 0.001) bowel satisfaction score, anal resting and squeeze pressures, squeeze duration and ability to retain saline infusion increased (P < 0.001), both immediately and at 1 year. Sensory thresholds decreased (P < 0.001). Conclusions: Biofeedback therapy produced sustained improvement in bowel symptoms and anorectal function. Because it is safe, inexpensive compared with other surgical interventions, and effective, biofeedback should be offered to incontinent patients unresponsive to medical therapy.",
author = "R. Ozturk and S. Niazi and M. Stessman and Rao, {Satish Sanku Chander}",
year = "2004",
month = "9",
day = "15",
doi = "10.1111/j.1365-2036.2004.02125.x",
language = "English (US)",
volume = "20",
pages = "667--674",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Long-term outcome and objective changes of anorectal function after biofeedback therapy for faecal incontinence

AU - Ozturk, R.

AU - Niazi, S.

AU - Stessman, M.

AU - Rao, Satish Sanku Chander

PY - 2004/9/15

Y1 - 2004/9/15

N2 - Background: In the short-term, biofeedback therapy improves symptoms and anorectal function in patients with faecal incontinence but whether there is long-term improvement is incompletely understood. Aim: To prospectively evaluate bowel symptoms and anorectal function, both immediately and 12 months after biofeedback therapy. Methods: A total of 105 consecutive patients (male/female = 12/93) with faecal incontinence, unresponsive to supervised medical treatment were enrolled in biofeedback training consisting of biweekly pelvic muscle strengthening exercises, anal squeeze and sensory-motor coordination training, and reinforcement sessions at 3, 6 and 12 months. Anorectal manometry, saline continence test, stool diaries and bowel satisfaction scores were used to assess improvement. Results: 94/105 (male/female = 10/84) completed training and 11 dropped out. Sixty completed 1-year assessment. At 1-year, 63% reported no episodes of incontinence. Biofeedback decreased (P < 0.001) stool frequency and number of incontinence episodes and increased (P < 0.001) bowel satisfaction score, anal resting and squeeze pressures, squeeze duration and ability to retain saline infusion increased (P < 0.001), both immediately and at 1 year. Sensory thresholds decreased (P < 0.001). Conclusions: Biofeedback therapy produced sustained improvement in bowel symptoms and anorectal function. Because it is safe, inexpensive compared with other surgical interventions, and effective, biofeedback should be offered to incontinent patients unresponsive to medical therapy.

AB - Background: In the short-term, biofeedback therapy improves symptoms and anorectal function in patients with faecal incontinence but whether there is long-term improvement is incompletely understood. Aim: To prospectively evaluate bowel symptoms and anorectal function, both immediately and 12 months after biofeedback therapy. Methods: A total of 105 consecutive patients (male/female = 12/93) with faecal incontinence, unresponsive to supervised medical treatment were enrolled in biofeedback training consisting of biweekly pelvic muscle strengthening exercises, anal squeeze and sensory-motor coordination training, and reinforcement sessions at 3, 6 and 12 months. Anorectal manometry, saline continence test, stool diaries and bowel satisfaction scores were used to assess improvement. Results: 94/105 (male/female = 10/84) completed training and 11 dropped out. Sixty completed 1-year assessment. At 1-year, 63% reported no episodes of incontinence. Biofeedback decreased (P < 0.001) stool frequency and number of incontinence episodes and increased (P < 0.001) bowel satisfaction score, anal resting and squeeze pressures, squeeze duration and ability to retain saline infusion increased (P < 0.001), both immediately and at 1 year. Sensory thresholds decreased (P < 0.001). Conclusions: Biofeedback therapy produced sustained improvement in bowel symptoms and anorectal function. Because it is safe, inexpensive compared with other surgical interventions, and effective, biofeedback should be offered to incontinent patients unresponsive to medical therapy.

UR - http://www.scopus.com/inward/record.url?scp=4644236257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644236257&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2004.02125.x

DO - 10.1111/j.1365-2036.2004.02125.x

M3 - Article

VL - 20

SP - 667

EP - 674

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 6

ER -